4月14日 - ** 药物开发商 GeoVax Labs GOVX.O 的股票在延时交易中下跌 16% 至 89 美分
** 美国卫生与公众服务部决定终止 GeoVax 的 COVID-19 疫苗 (link) 项目合同 - SEC 文件
** 终止合同的理由是 "方便政府"。
** GeoVax收到了先进技术国际公司（Advanced Technology International$(ATI)$）的停工通知，指示他们停止与项目有关的所有活动。
** 该项目由生物医学高级研究与发展局(BARDA) 资助，该局隶属于 HHS
** COVID-19 疫苗处于中期试验阶段
** 截至上一交易日收盘，股价累计下跌 5.7
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.